142 related articles for article (PubMed ID: 8478229)
21. Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma.
Klimberg VS; Langston JD; Maners A; Gocio JC; Hutchins LF; Lang NP; Westbrook KC; Broadwater JR
Am J Surg; 1992 Nov; 164(5):433-5; discussion 436. PubMed ID: 1443366
[TBL] [Abstract][Full Text] [Related]
22. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
[TBL] [Abstract][Full Text] [Related]
23. Combined modality preoperative therapy for unresectable rectal cancer.
Percarpio B; Bitterman J; Sabbath K; Alfano F; Ruszkowski R; Bowen J
Conn Med; 1992 Jan; 56(1):7-9. PubMed ID: 1547634
[TBL] [Abstract][Full Text] [Related]
24. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer.
Myerson RJ; Singh A; Birnbaum EH; Fry RD; Fleshman JW; Kodner IJ; Lockett MA; Picus J; Walz BJ; Read TE
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):665-74. PubMed ID: 11395234
[TBL] [Abstract][Full Text] [Related]
26. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
Gérard JP; Chapet O; Nemoz C; Romestaing P; Mornex F; Coquard R; Barbet N; Atlan D; Adeleine P; Freyer G
J Clin Oncol; 2003 Mar; 21(6):1119-24. PubMed ID: 12637479
[TBL] [Abstract][Full Text] [Related]
27. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
[TBL] [Abstract][Full Text] [Related]
28. Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study.
Wong CS; Cummings BJ; Keane TJ; Dobrowsky W; O'Sullivan B; Catton CN
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1291-6. PubMed ID: 1938526
[TBL] [Abstract][Full Text] [Related]
29. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
Stojanovic S; Popov I; Radosevic-Jelic L; Micev M; Borojevic N; Nikolic V; Krivokapic Z; Kecmanovic D; Gavrilovic D; Kezic I
Cancer Chemother Pharmacol; 2011 Sep; 68(3):787-93. PubMed ID: 21188380
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative concurrent radiochemotherapy for cancer of the rectum].
Berger C; Kirscher S; Félix-Faure C; Chauvet B; Vincent P; Brewer Y; Reboul F
Cancer Radiother; 1998; 2(3):260-5. PubMed ID: 9749124
[TBL] [Abstract][Full Text] [Related]
31. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
32. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation.
Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310
[TBL] [Abstract][Full Text] [Related]
33. Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma.
Haghbin M; Sischy B; Hinson J
Radiother Oncol; 1988 Sep; 13(1):75-81. PubMed ID: 3141984
[TBL] [Abstract][Full Text] [Related]
34. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
38. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Coia LR; Engstrom PF; Paul A
J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant treatment in operable stage II and III rectal cancer.
Aurelio P; Claudio C; Paolo M; Pierluigi G; Santina C; Domenico D; Numa C; Vincenzo V; Maurizio C; Fabrizio AI
Tumori; 1995; 81(3 Suppl):109-13. PubMed ID: 7571038
[TBL] [Abstract][Full Text] [Related]
40. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.
Valentini V; Coco C; Cellini N; Picciocchi A; Fares MC; Rosetto ME; Mantini G; Morganti AG; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):371-83. PubMed ID: 11567811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
